Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

TBVAC-HORIZON

Financiado

Cerrado

Improving understanding of lung immunity in tuberculosis to establish a diverse,...

Improving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity Tuberculosis (TB) remains one of the most devastating infectious diseases worldwide, killing over 4,000 people every day. Prevention of tuberculosis infection by novel vaccines would provide the most cost-effective approach to ach... ver más

31/03/2027

TBVI

7M€

Presupuesto del proyecto: 7M€

Líder del proyecto

STICHTING TUBERCULOSIS VACCINE INITIATIVE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-04-01

HORIZON-HLTH-2022-DISEASE-06-02-two-stage: Pre-clinical development of the nex... ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or...

I+D

Cerrada hace 2 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

TBVI

Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

IMAGING TB Deciphering mycobacterial subversion of early steps of adapt... 269K€ Cerrado

RTI2018-097625-B-I00 ESTUDIO INMUNIDAD INNATA ENTRENADA CONFERIDA POR LAS VACUNAS... 290K€ Cerrado

EMI-TB Eliciting Mucosal Immunity to Tuberculosis 8M€ Cerrado

BIO2014-52580-P INNOVANDO MTBVAC COMO VACUNA CONTRA LA TUBERCULOSIS Y NUEVAS... 315K€ Cerrado

AUTOPHAGTUBERCULOSIS MOLECULAR MECHANISMS OF AUTOPHAGY REGULATION IN TUBERCULOSIS 100K€ Cerrado

BAXERNA 2.0 Immunopeptidomics-based Development of Next-Generation Bacte... 9M€ Cerrado

Duración del proyecto: 47 meses Fecha Inicio: 2023-04-01
Fecha Fin: 2027-03-31

Líder del proyecto

STICHTING TUBERCULOSIS VACCINE INITIATIVE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 7M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Tuberculosis (TB) remains one of the most devastating infectious diseases worldwide, killing over 4,000 people every day. Prevention of tuberculosis infection by novel vaccines would provide the most cost-effective approach to achieve the goals of the WHO End TB strategy and the Sustainable Development Goals of the United Nations.While there are few promising TB vaccine candidates available, innovation by new platforms and strategies is needed to ensure that the most effective and affordable vaccines are developed. TBVACHORIZON will innovate and diversify the global TB vaccine pipeline by pursuing four objectives:1.Define the composition, spatial organisation and functioning of protective immune responses in the Mycobacterium tuberculosis-infected lung.2.Evaluate whether mucosal re-vaccination with BCG and other live attenuated vaccines improves protective efficacy against tuberculosis infection in mice, non-human primates and humans.3.Identify host immune response profiles and biomarkers of natural and vaccine-induced immune protection in the lung.4.Support next generation TB vaccine development by standardised head-to-head testing of selected vaccine candidates in animals and the establishment of novel delivery systems, adjuvant formulations and GMP platforms for live attenuated vaccines.TBVACHORIZON will increase our understanding and develop tools pertaining to immune protection in the lung, the major site of tuberculosis infection. This knowledge will be exploited to develop mucosal strategies for translating towards clinical evaluation and possible implementation. The interwoven activities will consolidate Europe’s leading role in TB vaccine research and innovation, with the ultimate goal of accelerated availability of affordable, accessible and more effective TB vaccines.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores